The Skinny On Skinny Labels

The law surrounding U.S. Food and Drug Administration section viii certifications is currently in flux due to recent decisions of the Federal Circuit, Novo Nordisk v. Caraco Pharm. Labs. Ltd. and...

Already a subscriber? Click here to view full article